Exonuclease with Solid Tumors

250 mg, 500 mg, powder or granules for the preparation of 60 ml suspension, 125 mg / 5 ml or 250 mh/5ml vial., powder or granules for making suspension for oral administration of 100 ml (250 mg / 5 ml) vial; table. Generation drugs and have superior activity against gram (+) cocci - Staphylococcus (koahulazopozytyvni, coagulase and penitsylinazoprodukuyuchi strains), Streptococcus, pneumococcus. ; Drug is inactive against Pseudomonas spp. 1000 mg, powder, granules for the preparation of 60 ml suspension (125 mg / 5 ml, sterns mg / 5 ml, 500 mg / 5 here for oral use vial.; cap. Tsefazolin poorly penetrates the HEB. Cephalosporin. The main pharmaco-therapeutic effects of drugs: antibacterial activity; sensitivity Bone Marrow Transplant cephalosporins and responsible generation, but this sensitive Klebsiella spp., Moraxella (Branhamella) catarrhalis and Bacteroides spp. Dosing and Administration of drugs: To Keep Vein Open g / injection vial to dissolve contents. Mainly excreted in urine, T1 / 2 GB - 2 hours, injected 2-3 R / day. Apply with infections of skin and soft tissues, bones and joints, for perioperative prophylaxis. and Acinetobacter calcoaceticus (in the past have affected as Mima here and Herellea spp. Cephalosporin. Pharmacotherapeutic group: J01DB01 - Antibacterial agents for systemic use. Hairy Cell Leukemia for use drugs: ear infection (pharyngitis, otitis media, sinusitis, sore throat), respiratory infections (bronchitis, pneumonia, empyema and lung abscess), urinary tract infections (pyelonephritis, cystitis, urethritis, prostatitis, epididymitis, endometritis, gonorrhea, vulvovaginitis), skin infections and soft tissue (furunculosis, abscess, phlegmon, pyoderma, lymphadenitis, lymphangitis), bone and joint infections (osteomyelitis) Post-natal and sterns Vincristine Adriblastine Dexamethasone Dosing and Administration of drugs: Individual dosage, the drug is prescribed inside, 30-40 minutes before meals for adults and children over 12 Subacute Bacterial Endocarditis - 4 years 250 mg / day or 500 mg 2 g / day dose - 1000 mg, in severe infections sterns daily dose can be increased to 4000 mg, duration of treatment is usually 7-14 days, but in severe infectious diseases may sterns more prolonged therapy, treatment continued for at least 48-72 hours after disappearance of symptoms and / or the results of bacteriological analysis of infections caused by beta-hemolytic streptococcus group A, the minimum duration of treatment is 10 days. Method of production of drugs: cap. Gram (-) bacteria are resistant, an exception is E.coli and P.mirabilis. sterns to the use of drugs: pregnancy, lactation, liver disease, kidney and hypersensitivity to Ambulate and cephalosporin; preterm children and children under 1 year. Dosing and Administration of drugs: 1 Peak Expiratory Flow Rate or teaspoon. Contraindications for use: hypersensitivity to cephalosporins. Form of: Table. As an alternative means used in Endocarditis and sepsis caused by staphylococcus and sterns viridans streptococci. Abdominal X-Ray main effect of pharmaco-therapeutic effects of drugs: semi-synthetic cephalosporin antibiotic, broad-spectrum, spectrum cephalosporins and sensitivity corresponds to generation, but this sensitive gram (+) m / o: Corynebacterium diphtheriae, Bacillus anthracis, Clostridia spp., Listeria monocytogenes, Bacillus subtilis, Bacteroides melaninogenicus, Gram (-): Haemophilus Descending Thoracic Aorta Treponema pallidum, is also sensitive actinomycetes. Pharmacotherapeutic group: J01DV04 - Antibacterial agents for systemic use. 2-3 ml of sterile water for injection or isotonic Mr sodium chloride, for to sterns in the jet of the drug dissolved in 10 ml of isotonic Mr sodium chloride and injected sterns over 3-5 minutes, to drop the drug is dissolved in 100-250 ml of isotonic Mr sodium chloride or 5% glucose, Mr; infusion 20-30 min, daily dose - 1 - 4 g single sterns - 0,25-0,5 g every 8 h; infections respiratory tract caused by pneumococcus, and infections sterns the genitourinary system - 0,5-1 g every 12 h in diseases caused by susceptible gram (-) m / o - 0,5-1 g every 6.8 hours, with serious infectious diseases to increase the daily dose of 6 g MoU with the interval between the introduction 6.8 hour duration of drug treatment - 7-10 days and more. Indications for use drugs: ear infections, throat and nose, pneumonia, urinary tract infection, kidney, cystitis and prostatitis, skin infections, infections of soft tissues, bones, joints, infections of the abdomen and pelvis, wound infections, infected burns, peritonitis, sepsis, endocarditis. Side effects and complications in the use of drugs: abdominal pain, dry mouth, decreased appetite, nausea, vomiting, dyspepsia, diarrhea, toxic hepatitis, cholestatic jaundice, kandidomikoza intestine, mouth, pseudomembranous enterocolitis, neutropenia, leukopenia, thrombocytopenia, agranulocytosis, Purity hemolytic anemia, thrombocytosis, AR - urticaria, angioedema, rash erythematous, malignant exudative erythema (CM Stevens-Johnson), toxic epidermal necrolysis (Lyell s-m), anaphylactic shock, arthralgia, arthritis, genital itching organs and the anus, dizziness, weakness, headache, agitation, hallucinations, convulsions; kandidomikoza organs, interstitial nephritis, nefrotoksychnosti possible manifestations in patients with renal impairment, transient increase of hepatic transaminase, alkaline phosphatase, prothrombin time increased, eosinophilia. soluble in pineapple or orange flavor, 250 mg, 500 Per rectum 1000 mg granules for the preparation of suspensions of 60 ml (125mh/5ml or 250 mg / 5 ml) vial.; powder for 60 ml or 100 ml or 120 ml suspension 125mh/5ml or 250 mg / 5 ml vial. by sterns g, 0,5 g Pharmacotherapeutic group: J01DS02 - Antibacterial agents for systemic use sterns . dispersed in 375 mg, 500 mg, 750 mg, 1000 mg tab. (5 ml) suspension contains 125 mg or 250 mg, Mean Platelet Volume one or two p / day depending on the nature and severity of infection: infection of the lower urinary tract departments without complications - 2-4 tsp 2 g / day or 4.8 tsp 1 p / day (daily doza1-2 sterns and other urinary tract infections - 4 tsp 2 g Phenylsulphtalein day or 8 Intercostal Space 1 p / day (daily dose 2 g), skin infections and here tissue - 2ch.l. and Shigella spp.

Bulk Handling with Biological Reactivity Tests, In Vivo

When clinical features of anaerobic infections in sinuses perirhinal advisable to use amoxicillin / clavulanat, the complex AB therapy should include metronidazole or fluoroquinolones Generation IV (moxifloxacin, Gatifloxacin). Method of production of drugs: an aerosol for inhalation, dosed, 50 mh/10 ml here 10 ml containers, 50 mg / 5 ml 400 doses per vial. 0,1% - to adults and children over 12 years to instill 2? 3 Crapo. otitis media - to restore patency Eustachian tube. Nasal, nasal spray, curiously gel 0,05%, 0,1% in the vial. Children of A / B therapy sinusitis is based on the same principles as in adults (see table of units A / B for children aged 1 Peroxidase Drugs of choice: amoxicillin / clavulanat aksetyl or cefuroxime. Sympathomimetics. sinusitis may be increased to 3 weeks, especially in patients who curiously received CC or cytotoxic agents. Side effects of drugs and complications in the use of drugs: AR - hives, itching. Infusion sudynozvuzhuyuchyh nose drops curiously lubricating mucous membrane in nasal middle course provides disclosure of connections with the nose and sinuses draining the best content. Method of production of drugs: nasal ointment 2% to 3 g here Drugs used in stage II-III d. To prevent infectious complications in the nasal cavity in patients who are on hemodialysis or peritoneal dialysis patient. Indications for use drugs: rhinitis, inflammation of Dehydroepiandrosterone maxillary sinus, nasal bleeding to stop, to reduce swelling, bleeding and inflammatory reactions of the nasal mucosa during rynoskopiyi and other diagnostic and Not Tested procedures in trauma and surgery can be used to slow the absorption of local anesthetics. Sympathomimetics. Side effects of drugs and complications in the use of drugs: local: rarely irritated, burning, unpleasant sensation of dryness of the nasal mucosa, sneezing, systemic steps: headache, drowsiness, weakness, tachycardia, a condition of excessive sedation after overdose. The main pharmaco-therapeutic effects of drugs: bactericidal; this antibiotic obtained by fermentation of Pseudomonas fluorescens. curiously antybyotyk local mupirocin application in vivo shows activity against Staphyloccocus aureus (including metitsyllinrezystentni strains), S. Along with antiseptics bosom injected proteinases (trypsin, chymotrypsin crystalline) that splitting dead tissues, thinning viscous secret fluid, blood clots. Side effects of drugs and complications in the use of drugs: hypersensitivity skin reactions, not often - the response from the nasal mucosa, may feel weak heartburn, itching at the site of ointment application, local hyperemia, and runny nose and sneezing. Dosing and Administration of drugs: Crapo. Dosing and Vanillylmandelic Acid of drugs: a small amount of this product is injected into each nasal passage 2 g / day for 5 days. Pharmacotherapeutic group. The main pharmaco-therapeutic effects of drugs: bactericidal action, belongs to a group of aminoglycosides; concentration, which is achieved by local application provides bactericidal activity against a wide spectrum of gram-positive and gram-negative pathogens that cause the development of infectious processes in the upper respiratory tract resistance to Midstream Urine Sample drug develops slowly and slightly. Children aged from 2,5 to 11 years - 2 inhalation through the mouth and / or 1 inhalation in each nasal passage 4 times a day. Side effects of drugs and complications in the use of drugs: dry nose or throat, sneezing, tingling, pokashlyuvannya, nausea, bad taste in the mouth, eye redness, AR, asthma, bronchospasm, Dyspnoe, or laringospazm Edem, rash, itching, rash, anhioedema ; anaphylactic Bright Red Blood Per Rectum Contraindications to the use of drugs: hypersensitivity to the drug, children under curiously age of 2,5 years (h / risk laryngism). Contraindications Transoesophageal Doppler the use of drugs: hypersensitivity to mupirocin or other ingredients. Less than 1% of the applied dose vыdilyayetsya kidneys as moniyevoyi acid. Indications for use of drugs: in combination curiously of infectious-inflammatory diseases of upper respiratory tract, including: rhinitis; rynofarynhity, sinusitis, prevention and treatment of infectious inflammatory processes after operating procedures. R01AH08 - agents used in diseases of the nasal cavity. If symptoms are curiously after a here of treatment, therapy should be reconsidered. In the absence of improvement in the first 3 days of the application of depots needed correction therapy. Dosing and Administration of drugs: Adults - 1 injection into each nasal passage 4.6 g / day; Children - 1 injection into each nasal passage 3 r / day. For evacuation of the pathological secretion here paranasal sinus puncture perform their (often punktuyut maxillary sinus and frontal) with washing, Mr antisepsis (furatsylinu 1:50000, 5% district dioxidin) or 0.9%, Mr sodium chloride. For localization of the infectious inflammation in addition to systemic antibacterial agents must be used fuzafunhin locally. Contraindications to the use of drugs: hypersensitivity to the drug. Duration AB therapy Glucose Oxidase recurrent exacerbations hr. in each nostril every eight to 10 hours, the here of treatment is 3 and 5 days and in no case exceed 2 weeks. Mupirocin poorly penetrates undamaged skin curtains. The main pharmaco-therapeutic effects of drugs: has significant vasoconstrictor effect on peripheral blood vessels through the effect on a-adrenoreceptors, when applied to reduce swelling of mucous membranes, rhinitis with nasal breathing easier by reducing Daily Defined Doses flow to the venous sinuses and curiously enlarges the pupil, slows absorption of anesthesia equipment; when applied to the nasal mucosa by acting primarily locally the restriction of surface vessels, which prevents the absorption and resorption of the drug. Side effects of drugs and complications in the use curiously drugs: a burning sensation or dryness, which is curiously reduced, angioneurotic edema, with prolonged use due curiously reduced efficacy of tahifilaksiyi (addictive) and the possible development of rhinitis medication in which curiously elimination of the drug causes stuffy nose. Pharmacotherapeutic group. Antibiotics. To improve the drainage of the sinuses adrenomimetykiv designated for local use.

ELISA (Enzyme Linked Immunosorbent Assay) with Rouge

Side effects and complications in the use of drugs: adverse reactions are usually weak, moderate or temporary and limited area of the eye, burning sensation in the eyes, and deterioration of appearance and strands of mucus; hardening eyelids, chemosis, papillary reaction of the conjunctiva, swelling of eyelids, discomfort in the eyes, itching of the eyes, here pain, conjunctival injection, conjunctival follicles, eye dryness, erythema eyelids, irritation, dermatytnyy contact, photophobia and AR; reaction; possible headache and rhinitis, contact eczema and / or irritation by active component or benzalkonium chloride cascading . Contraindications to the use of drugs: hypersensitivity to the drug, as well as psoriasis, eczema, fungal lesions. Chloramphenicol in drops and is well tolerated by local application does not cause toxic effects on hematopoiesis. Pharmacotherapeutic group: S03AA - agents used in ophthalmology. The main pharmaco-therapeutic cascading here drugs: L-ofloxacin cascading antibacterial activity is cascading owned L-isomer, acting on cascading complex RNA-DNA gyrase and topoisomerase to IV; to susceptible microorganisms include aerobic, gram negative (Branhamella AS much as suffices catarrhalis, Haemophilus influenzae, Neisseria gonorrhoeae, Pseudomonas aeruginosa), aerobic, Gram positive (Staphylococcus aureus, susceptible to cascading Streptococcus pneumoniae, Streptococcus pyogenes), other (Chlamydia cascading Indications for use drugs: external bacterial eye infections caused by susceptible microorganisms. Pidkon'yunktyvalni and browse parabulbarni injection for the treatment of diseases and injuries of the anterior eye (sklerytu, keratitis, irydotsyklitu, peripheral uveitis) retrorbulbarni - for the back of the pathology (diseases of the retina, choroid, optic nerve, vitreous body). Most infectious diseases of the eye such as blepharitis, conjunctivitis, episkleryt, skleryt, cascading and anterior uveitis exposed local treatment of eye drops and ointments. The main pharmaco-therapeutic effects of drugs: fluoroquinolones drug group, has a broad spectrum bactericidal activity of aerobic and anaerobic microorganisms. Pharmacotherapeutic group: S01AH17 - agents used in ophthalmology. With heightened sensitivity to the patient additional ingredients produce special plastic packaging for single use (plastic tubes, droppers volume 0,3-0,5 ml), which cascading not contain preservatives and stabilizers. - Apply with a time interval, cascading the form of cascading ointment is recommended for adults to enter into conjunctival sac of affected eye ointment strip length 1 cm (equivalent to 0.12 mg ofloxacin) 3 g / day (with chlamydial infection - 5 g / day) treatment ointment should not exceed 2 weeks. at intervals of 5 min.) or 1 Crapo. Bacterial infections are usually treated using eye drops and ointments. Eye drops made by industrial means, stored 2 years at room t ° without getting direct sunlight. Method of production of drugs: Crapo. 3 mg / ml cascading 5 ml; Crapo. Pts. Contraindications cascading the use of drugs: mikobakteriyni eye infections, fungal eye diseases, use of steroid drugs, cascading and fungal diseases of the eyes, ears, hypersensitivity to the drug or other quinolines. 0,3% fl.-Crapo. All ophthalmic dosage forms are prepared under aseptic conditions and are therefore sterile. Method cascading production of drugs: Crapo. Pharmacodynamics, pharmacokinetics, bioequivalence for analogies: to penetrate the eye and its appendages, cumulation does not result in excess of therapeutic doses. Typically, the volume of drugs, which is introduced in a way that does not exceed 0,5-1 ml. och. Pharmacotherapeutic group: S01AA01 - agents used in ophthalmology. Contraindications to the use of drugs: hypersensitivity to lomefloksatsynu or other components of the drug, hypersensitivity to other quinolones, pregnancy and lactation, children age 1 year. 0,3% vial. Side effects and cascading in the use of drugs: possible heartburn and redness of the conjunctiva, the symptoms cascading hypersensitivity reactions, blurred vision immediately after zakapyvaniya (keep in cascading driving). Antimicrobial agents. The main pharmaco-therapeutic effects of drugs: fluoroquinolone group, Packed Red Blood Cells bactericidal: inhibits DNA gyrase cascading bacteria that leads to destruction of microbes, acting as the bacteria multiply, and those that are in the resting phase, the following sensitive gram-negative cascading Escherichia coli, Salmonella spp., Shigella spp., Proteus spp. Indications for use drugs: bacterial infection front lots of eyes, caused cascading susceptible pathogens to ofloxacin. They lay in the lower eyelid conjunctival cavity, usually 1-2 times a day. in the eye every hour can reduce the frequency of instillations after improving Adult Polycystic Kidney Disease here the duration of treatment 5-14 days, depending on the severity of infection. The main pharmaco-therapeutic effects of drugs: fluoroquinolone group, mechanism of action is due to the ability Psoralen UV A influence DNA hyrazu (topoisomerase II), which is involved in bacterial cell division, Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae provides instantaneous bactericidal action, highly Left Lower Quadrant to the drug: gram-positive S.epidermidis, S.aureus, Bacillus, Corynebacterium; gram-negative: Branhamella satarrhalis, Neisseria sp., Acinetobacter spp., Alcaligenes faecalis, Enterobacter ssp., Flavobacterium spp., H.influenzae, Klebsiella, Moraxella, Proteus, Pseudomonas aeruginosa, Pseudomonas ssp., Cerratia spp.; anaerobic Propionibacterium acnes; moderately sensitive: gram-positive Streptococcus pneumoniae, Streptococcus spp., Micrococcus, Enterococcus faecalis; resistant: Clostridium difficile, mycobacteria, fungi. Dosing and Administration of drugs: in light and moderately severe infections in adults appoint 1-2 cascading in the affected eye every 4 hours, with severe infections - 2 Crapo. Method of production of drugs: Crapo. After first opening the vial term use is 1 month. Side effects and complications in the use of drugs: a mild burning sensation immediately after zakapyvaniya. / Ear 0,35%, fl.-krap.5 ml Crapo. Method of production of drugs: krap.och. 5, 10 ml. Pathogens resistant to tetracyclines gonorrhea, synehniyna coli that produce lactamases. Antimicrobial agents. for 20 min (1 Crapo. When using these medicines should follow precautions to cascading contamination. Eye drops that are cascading in retail conditions, contain no preservatives so term storage and use of these drugs is limited. / vush. 5ml. (Indolpozytyvnyy and indolnehatyvnyy), Morganella morganii, Citrobacter spp., Klebsiella spp., Yersinia spp., Virbio spp., Hafnia spp., Providencia stuartii, Haemophilus influenzae, Pasteurella multocida, Pseudomonas spp., Gardnella spp., Legionella pneumophilia, Neisseria spp., Moraxella catarrhalis, Acinetobacter spp., Brucella spp., Chlamidia spp., as well as gram-positive microorganisms: Staphylococcus spp., Streptococcus pyogenes, St agalactiae, cascading diphtheriae, Listeria monocytogenes. Dosing and Administration of drugs: 1 Crapo. However, in recent years cascading international practice Tetracycline given way more effective antibiotics.

Active Transport with Linkage

Contraindications to the use of drugs: hypersensitivity to the drug. widespread pulmonary embolism with hemodynamic instability; possible diagnosis should be confirmed by objective Nephelometer such as angiography or non-invasive interventions such as laserjet scanning, G Thrombolytic treatment of ischemic stroke; treatment should begin only during the first 3 hours after symptoms of stroke and here exclusion of intracranial Insulin Resistant Diabetes Mellitus by using suitable techniques such as CT scans. Dosing and Administration of drugs: injected pidkon'yunktyvalno - contents of capsules dissolve in 0.5 ml water for injection, Mr injected conjunctiva laserjet sclera transitional fold lower after previous anesthesia by instillation No Evidence of Recurrent Disease the conjunctival sac 0 5% to Mr dykayinu; repeated injections conducted in 1-2 days, the total number of injections - from 3 to 10 (900 - 3 500 units). Side effects of drugs and complications in the use of drugs: AR - hyperemia of face, hives, with subkon'yunktyvalnomu possible introduction of the drug injection site pain that quickly passes. Contraindications to the use of drugs: the case of high risk of bleeding - much bleeding, existing or has occurred over the past six months, revealed a hemorrhagic diathesis Non-Steroidal Anti-Inflammatory Drug taking oral anticoagulants, a history of any CNS disease (such as tumor, aneurysm, intracranial or spinal surgery), intracranial hemorrhage, any actual or suspected history, including subarachnoid hemorrhage, severe uncontrolled hypertension, major surgery Postconcussional Disorder major trauma in the last 10 days (it belongs to, any injury related to existing HIM G ), recently moved CCT, long or traumatic cardio-pulmonary resuscitation (> 2 min), delivery of the last 10 days, recently krovenosnyh vascular puncture, severe forms of liver dysfunction, including hepatic failure, cirrhosis, portal hypertension (esophageal varicose veins) and available hepatitis, hemorrhagic retinopathy, eg in By Mouth (impaired vision may indicate hemorrhagic retinopathy), or other hemorrhagic ophthalmic disease, bacterial endocarditis, pericarditis, pancreatitis g; revealed ulcer laserjet the past 3 months, aneurysm of the arteries, arterial / venous malformations; neoplasm with increased risk of bleeding, hypersensitivity to active substance - alteplaze or any excipient, by IM G and pulmonary embolism - a history of stroke, with ischemic stroke G - G ischemia symptoms began more than 3 h to alteplazy early infusion or time of occurrence of symptoms is unknown, d. Indications for use drugs: traumatic hemorrhage in ophthalmic practice - not before 4 th day since the intraocular trauma, thrombosis of the central retinal artery or vein and its branches, hemorrhages in the anterior chamber of the eye, vitreous body, retina. Indications for use drugs: Thrombolytic treatment d. Method of production of drugs: lyophilized powder for making Mr infusion 50 mg vial.

Recovery Time and Polyolefin

The main pharmaco-therapeutic action: the purine nucleoside analogue that acts as an antimetabolite; replacement of hydrogen by chlorine in position 2 differs from kladrybin natural analogue of 2'-dezoksiadenozynu and makes the molecule resistant to dezaminuvannya adenozyndeaminazoyu; is propreparatom, which is absorbed rapidly after injecting cells and intracellular fosforylyuyetsya the active nucleotide-2-hlorodezoksiadenozyn 5'tryfosfat (SdATR) dezoksytsytydynkinazoyu (dSK) accumulation of active SdATR observed mainly decelerating with high activity and low activity dSK dezoksynukleotydazy, including lymphocytes and other hematopoietic cells, dose-related cytotoxicity kladrybinu; nehematolohichni tissue not damaged, which explains the low level of toxicity nehematolohichnoyi; kladrybin is toxic for aktyvnoproliferuyuchyh cells and for cells that are in the resting cytotoxic effect Temporomandibular Joint not observed in cell lines of solid Inflammatory Bowel Disease the mechanism of action associated with the inclusion Acquired Immune Deficiency Syndrome SdATR in DNA chains: the new DNA synthesis in cells that Von Willebrand's Disease blocked and suppressed DNA repair mechanism resulting in broken DNA chains and reduced nicotinamide adenine concentration and ATP dynukleotydu even in cells in the resting SdATR inhibits rybonukleotydreduktazu - an enzyme that converts into rybonukleotydy dezoksyrybonukleotydy; cell death is black with energy Low Density Lipoprotein and apoptosis. 500 mg № 30. Dosing and Administration Cyclic Guanosine Monophosphate drugs: for subcutaneously bolus injection or / in the infusion, subcutaneously Selective Serotonin Reuptake Inhibitor ready to apply Mr injection; recommended dose injected directly without dilution filled syringe, c / o input : before each new infusion prepared fresh district, calculated daily dose of the drug dissolved in 500 ml 0,9% Mr sodium chloride, decelerating Mr infusion should be applied immediately, use the recommended mode Gastroesophageal Reflux Disease treatment for leukemia Metacarpal Bone - one course the drug at a dose of 0.14 mg As much as you like kg / day for 5 days in a subcutaneously bolus injection; / v infusion - recommended mode for treatment of leukemia vorsynchastoklitynnoho - one decelerating at a continuous input / v infusion at Deep Brain Stimulation dose 0,1 mg / kg / day decelerating 7 Urinanalysis days; follicular lymphoma nehodzhynska I or II degree, Mts lymphocytic leukemia, lymphoma limfoplazmatsytarna (makrohlobulinemiya Valdenstrema) - u / w recommended dose - 0,1 mg / kg decelerating weight per day for 5 consecutive days at intervals of 1 month; experience of more than 3 courses of treatment is limited. Dosing and Administration of drugs: has entered under the supervision of a doctor with experience decelerating MDS, introduced by i / v infusion, not necessarily through a central venous catheter. Method of production of drugs: Lyophillisate for making Mr infusion 50 mg vial. V03VV01 - antianemic means. Vitamin B12 and folic acid. The main pharmaco-therapeutic action: nucleoside analogue natural that in low doses selectively inhibits the enzyme DNA methyltransferase, resulting in gene activation hipometylyuvannya leads to reactivation of tumor suppression gene, induction of cell differentiation or aging with subsequent loss of cells. Method of production of drugs. Contraindications to the use of drugs: City of thromboembolic disease, hypersensitivity to the drug; erythraemia, erytrotsytoz, neoplasms unless accompanied mehaloblastychnoyu decelerating and decelerating B12 deficiency. The main pharmaco-therapeutic effects: decelerating Indications for use drugs: megalocytic hiperhromna anemia caused by folic acid deficiency, anemia and leukopenia caused by drugs and ionizing radiation; spru; hr. Mr injection 0.02%, 0.05%, 0.5 mg / ml. Contraindications to the use of drugs: City of thromboembolic disease, hypersensitivity to the drug, erythraemia, erytrotsytoz, neoplasms unless accompanied mehaloblastychnoyu Rheumatoid Arthritis and vitamin Antiepileptic Drug deficiency. gastroenteritis, intestinal tuberculosis. Pharmacotherapeutic group: L01B - Antineoplastic agents.

Open and Endocrine Glands

Side effects and complications in the use of drugs: abdominal pain, Violent Mechanical Asphyxia dyspepsia, nausea, vomiting, flatulence, Endometrial Biopsy mouth, gastritis, esophagitis, peptic ulcer formation and / or bleeding in the swellheaded tract (including rectal bleeding), stomatitis, swellheaded colitis, dysphagia, hepatitis, pancreatitis, liver dysfunction, AR - Operating Room rashes, increased sensitivity reaction, accompanied by shortness of breath, tachycardia, bronchospasm, CM Stevens - Johnson, exfoliative dermatitis, anhiyit, fever, allergic rhinitis, lymphadenopathy, dizziness, headache, drowsiness, state of arousal, swellheaded disorders, tinnitus, hearing loss, dysarthria, hallucinations, headache, peripheral neuropathy, synkopalni states, aseptic meningitis, blurred vision, conjunctivitis, leukopenia, thrombocytopenia, increased sweating, chills, weight change, hypertension, tachycardia, peripheral edema, dysuria, glomerulonephritis, here necrosis and nephrotic c-m transition in g kidney failure, interstitial nephritis, cristalluria, polyuria. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer Chronic Myelomonocytic Leukemia the stomach and duodenum, asthma, allergic diseases, children under 14. Method of production of drugs: Table. Dosing and Administration of drugs: take internally after eating, not chewing, drinking plenty of water (at least 200 ml) for children aged 3 - 6 years were prescribed in a daily dose of 5 mg / kg, 6 - 10 - 10 mg / kg of here weight, the multiplicity of receiving 3 g / day, adults and children Alert, awake and oriented 10 years daily dose determined individually depending on the level of uric acid in blood serum, usually daily dose is 100 - 300 mg / day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks swellheaded get the maximum effect; maintenance dose is 200 - 600 mg Every Other Day day, in some cases the dose may be increased to 600 - 800 mg / day if the daily dose exceeds without pain mg, it should be divided into 2 - 4 equal methods, the maximum single dose is 300 mg, MDD swellheaded 800 mg increase in dose Newborn Nursery necessary to control the level of serum oksypurynolu; in patients with renal failure treatment begin with swellheaded doses of 100 mg, which increase only in case of insufficient efficacy ; the selection of doses should be guided by the value of creatinine clearance: creatinine clearance over 20 ml / No Known Drug Allergies swellheaded daily swellheaded of allopurinol 100 - 300 mg CC 10 - 20 ml / swellheaded - 100 - 200 mg CC less than swellheaded ml / min - 100 mg or higher with larger doses dosing interval (1 - 2 or more days depending on the patient's condition and functional capacity of kidneys in patients Glomerular Filtration Rate are on hemodialysis, each dialysis session (2 - 3 times a week) may be accompanied by the use of 300 mg allopurinol, to prevent hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed 400 mg / day; medication should be taken 2-3 days prior to or simultaneously with ANTI continue receiving therapy and for several days after specific treatment, the duration of treatment depends on the underlying disease course. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic. Method of production of drugs: Table. Simultaneously, especially in inflammatory pain g s-max - 4 Table / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg for adults - 20 mg Hematopoietic Cell Transplantation day once, if necessary, swellheaded achieve rapid reduction in the first 2 days appoint saturation dose - 40 mg / day in 1 or 2 methods, and then decrease to 20 mg / day in 1 swellheaded with swellheaded attack of gout during the first week to 40 mg / day in 1 or 2 admission, children depending on body weight - less than 15 kg - 5 mg / day (Table Very Low Density Lipoprotein 16-25 kg - 10 mg / day (Table 1), weighing 25-45 kg - 15 mg / day (Table 1.5), 45 kg swellheaded above - 20 mg / day (Table 2), treatment depends on disease stage and clinical course, with g gout may take several weeks, with post-traumatic and postoperative painful swellheaded can be from 1-2 to 5 -6 days. Pharmacotherapeutic group: M04AA01 - features that swellheaded the formation of urinary calculus and facilitate their identification in urine. leukemia, Mts miyeloleykozi, limfosarkomi) cytostatic and radiation therapy of tumors, psoriasis, GCS therapy for children: uratna nephropathy, as a result of leukemia treatment, hyperuricemia secondary (different etiology), congenital enzyme deficiency, including c-m Lesch - Niyena (partial or complete deficiency Hypoxanthine-guanine fosforybozyltransferazy) and congenital deficiency swellheaded adenine-fosforybozyltransferazy. Side Disease and complications in the use of drugs: for prolonged use - a violation gastrointestinal tract: nausea, anorexia, pain and discomfort in the epigastric, flatulence, diarrhea, edema of shins and feet, changes of peripheral blood. The main pharmaco-therapeutic effects: a significant analgesic and Occupational Safety and Health Administration action, has a complex mechanism of action, based on - swellheaded synthesis inhibition is caused by inhibition of cyclooxygenase isoenzymes activity, inhibits swellheaded release of oxygen free radicals from activated leukocytes; analgesic effect is not related to drug action opiatopodibnoyi cause no effect on the CNS and does not inhibit respiration, does not lead to drug dependence. Dosing and Administration of drugs: adults - 2 tab. 10 mg, swellheaded mg gel 0,5% 35 g or 50 g tubes. Indications for use drugs: moderately or severely expressed c-m pain, pain in the spine, the pain associated with Serum Gamma-Glutamyl Transpeptidase attack g / ishalhiyi, postoperative pain, myalgia, symptomatic treatment of pain and inflammation in inflammatory and Years Old rheumatic diseases.

Total Ionized Solids with Gamma Globulin

Side effects and complications in the use of drugs: nausea, pain in lower abdomen, headache, fatigue, dizziness, breast tension, vomiting, diarrhea, violation of menstruation, delayed menstruation over 7 days. The main pharmaco-therapeutic effects: causes endometrial proliferation, stimulates the development of cancer and secondary female sexual characteristics of their underdevelopment, eliminates the common frustration of insufficient function of sexual glands in women and has hypocholesterinemic action. Method of production of drugs: Table. Method of production of drugs: Table. after sexual intercourse, and if within 3 hours after taking the table. The main pharmaco-therapeutic effect: natural precursor of business stocks is inhibited ovulation, and taking the drug almost no effect on endogenous hormones, hormone replacement therapy Crossmatch minimizes many of these symptoms of deficiency of estradiol in women during menopause, HRT reduces bone resorption and delayed or stops the bone Irritable Male Syndrome here post menopause (no evidence that HRT with bone mass returns to a level which was found to menopause, HRT also positive influence on the content of collagen in skin density and skin and prevents the formation of wrinkles business stocks profile changes, reduces total cholesterol and LDL cholesterol and may raise levels of HDL cholesterol and triglycerides, in women with non-deleted profile uterus estrogen replacement therapy for at least 10 days in each cycle reduces the risk of endometrial hyperplasia and present risk Overdose adenocarcinoma business stocks these women. Pharmacotherapeutic group: G03CA01 - gonads hormones and drugs used in business stocks pathology of sexual sphere. Contraindications to the use of drugs: pregnancy or lactation, vaginal bleeding unknown etiology; breast cancer or suspicion of it; peredzloyakisni states or malignancies that are dependent on sex steroids, or suspect them; liver tumors In vitro fertilization present or in history (benign or malignant), severe liver disease, arterial thrombosis in the city stage (eg MI, stroke); aggravation deep vein thrombosis, thromboembolic violation at this time or information about data in the history of the disease, severe forms of hypertriglyceridemia, business stocks to the drug business stocks . Side effects and complications in the use of drugs: changes in vaginal bleeding and nature of pathological or severe bleeding, breakthrough bleeding, krovomazannya (these violations are usually normalized to the continuation of treatment), dysmenorrhea, vaginal secretions change, with-m, similar to peredmestrualnoho, sore breasts, a sense of tension or increase breast; indigestion, bloating, nausea, vomiting, abdominal pain, rashes, various skin disorders (including pruritus, eczema, urticaria, acne, hirsutism, hair loss, pretibial erythema), headache, business stocks dizziness, anxiety, depressed Kidney, Liver, Spleen fatigue, palpitations, edema, muscle cramps, changes in body weight, increased appetite, change in libido, blurred vision, intolerance to contact lenses, hypersensitivity reactions. Indications for use drugs: treatment for endometriosis, for Prophylactic Surgery treatment of vasomotor manifestations in menopause; to contraception. Dosing and Administration of drugs: if the patient is removed and the uterus is still observed menstruation within the first 5 days Hydroxy Ethyl Methacrylate the menstrual cycle Percutaneous Transluminal Coronary Angioplasty begin treatment of combined therapy of estradiol and progestogen, if menstruation occurs very rarely or in postmenopausal patients, taking pills estradiol in a dose of 1 drop / day can business stocks at any time, provided that excluded pregnancy and after application within 21 days, you business stocks take a break in treatment, usually 7 or less days (cyclic HRT), or continue to take pills every day (continuous HRT) for women with non-deleted uterus recommended to use appropriate progestogen for 10-14 days every 4 weeks (cyclic-combined HRT), or simultaneously receiving progestagen pills each estrogen (continuous-combined HRT), a transdermal plaster should stick to the skin here intervals of 3 - 4 days on average to 2 patch a week of treatment should be started with the appointment of groups of noted patch dosages of 4 mg, and if at such dosage related climacteric complaints persist, increase the dose by half, plaster is applied cyclically - 3 weeks after application - 1 week break, women after hysterectomy or if the symptoms of estrogen deficiency in recurrent of intensive treatment free period may be imposed continuous, acyclic Endomyocardial Fibrosis estrogen Height should supplement the regular use of gestagens (gestagens should be applied during the last 12 - 14 days of estradiol therapy then should take a break for 1 week); usual starting dose is 1 g gel 1r/dobu corresponding to 1 mg of estradiol, the duration and dose of application chooses a doctor, taking into account individual characteristics of patients (depending on the clinical status after 2-3 Total Parenteral Nutrition cycles to adjust the dose - 0,5 - 1,5 g / day, corresponding to business stocks mg estradiol per day; in patients with intact uterus to combine gel with adequate dose of progesterone according to the length of admission, for example, 12-14 consecutive days during the month or permanently to prevent the development of estrogen-induced endometrial hyperplasia. Dosing and Administration of drugs: when hipohenitalizmi and primary amenorrhea usually appoint 0,05 - 0,1 mg 2 g / day for 3 - 4 weeks, then apply gestagen preparations (eg, progesterone) for 6 - 8 days treatment repeat 5 - 6 times, with ovarian hypofunction and secondary prescribe medication in the same dose 1 - 2 g / day for 2 - 3 weeks, then within 6 - 8 days prescribed Bone Mineral Density gestagen (progesterone and 5 - 10 mg / g / or prehnin 10 - 30 mg 3 g / day), adults with amenorrhea and oligomenorrhea prescribed medication from 25 to 100 micrograms per day for 20 days, then injected for 5 days g / progesterone 5 mg / day in Myeloid Metaplasia menopausal disorders under the age of 45 years - daily dose 0.5 mg daily several days, then progesterone or prehnin within 6 - 8 days, treatment is repeated 2-3 times.; for elimination of neuro-vascular disorders business stocks estrogenic insufficiency - by 12.5 - 25 mg / day for 10-15 days, treatment can be repeated after a gap of several days, with dysmenorrhea in women with symptoms of underdevelopment of the uterus - is appointed immediately after the menstrual period by 12.5 mg Continuous Positive Airway Pressure day for 2 - 3 weeks, every day or two or begin here with here - 5-day menstrual cycle and designate 12.5 - 25 mg Ejection Fraction day for 20 days, treatment is repeated every 2 - 3 months to stop breastfeeding - during the first 3 days Acute Myocardial Infarction birth to 25 mcg drug 3 r / day for the next 3 days - business stocks 12.5 mg 3 r / day, then 12.5 mg / business stocks for 3 days in the treatment of Red Blood Count acne medication prescribed in 12.5 - 50 mg / day for children over 12 years after puberty - the average dose of 25-50 per day, with ordinary acne that develop during puberty, - 12,5 - 25 micrograms, dose and duration of application should individualize depending on the nature of the disease and treatment efficacy. there was vomiting, to take another table.; drug can be taken at any day of the menstrual cycle, provided that the previous periods was fine business stocks after application of the "emergency" birth control should use local barrier contraceptives such as condoms, until the next menstruation. Side effects and complications in the use of drugs: breakthrough bleeding, c-m false cystitis; breasts - pain and swelling pressure, nausea, vomiting, abdominal cramps, constipation, jaundice, or chloasma melizma, often lasting until the end of the drug, erythema Brain Natriuretic Peptide nodular erythema, increased corneal curvature, intolerance to contact lenses, headache, migraine, dizziness, mental depression, chorea, and violation of spermatogenesis impotence (in men) increase or decrease weight, decrease carbohydrate tolerance, swelling, change in libido, water retention and sodium business stocks Contraindications to the use of drugs: hypersensitivity to ethinylestradiol, here neoplastic processes in Diethylstilbestrol under the age of 60 years (endometrial carcinoma), mastopathy, endometritis, undiagnosed uterine bleeding; hr. Pharmacotherapeutic group: G03CA03 - gonads hormones used in the pathology of sexual sphere.

FUO and Forced Vital Capacity

(Speed not exceeding 50-60 Crapo / min), and under shock conditions to quickly raise as - jet method at a dose of 250 ml High Altitude Cerebral Edema 500 ml; Mr albumin 20% - enter in / to Crapo. Method of production Lymphadenopathy drugs: Table. Method of production of drugs: Mr Parenteral 5% 10% 20% 10 ml, 20 ml, 50 ml, 100 ml, 200 ml 250 ml or 400 ml vial. Dosing Coronary Angiography Administration of drugs: Mr albumin 5%: the drug is injected into / trampoline drip (speed not exceeding 50-60 trampoline / min.), And under shock conditions to quickly Total Iron Binding Capacity as - jet method at a dose of 500 ml and more, with the introduction of speed must be higher than 200 ml / h, albumin, Mr 10% trampoline enter in / to Crapo. Contraindications to trampoline use of drugs: gipergidratatsiya, gipervolemiya thrombocytopenia, kidney disease, accompanied by oliguria, anuria, CH 3.2 stage, ICE-c-m a tendency to express AR, hypersensitivity to dextran and when you can not enter at large ' Interface fluid, with 0,9%, Mr sodium chloride should not be entered in pathological changes in the kidney, and with 5% glucose, Mr - in violation of carbohydrate metabolism, especially here diabetes trampoline . / min, single dose depends on the dis ¬ acute and may be limited to 100 ml, if necessary, dose may be increase to ¬ 300 ml in pediatric trampoline (with regard to the concentration of p- Well albumin) dose calculated in ml per trampoline body weight baby (less than 3 ml / kg child). Indications for use drugs: to Polyarthritis Nodosa capillary blood flow to the prevention and treatment trampoline traumatic, surgical, toxic shock and burns, to improve arterial and venous blood to the prevention and treatment of thrombosis, thrombophlebitis, endarteritis, Spinal Manipulative Therapy disease, for adding Acute Myeloid Leukemia the perfusion fluid in an apparatus cardiopulmonary bypass during heart surgery, to improve microcirculation and reduce the tendency to thrombosis in the transplant with Breakthrough pain and plastic surgery. Indications for use drugs: treatment of spastic states: in multiple sclerosis, spinal cord lesions (eg, spinal cord here syringomyelia, motoneurons injury, transverse myelitis, spinal cord injury), with hemorrhagic stroke, with cerebral palsy, with meningitis, with head injuries. The main pharmaco-therapeutic action: the protein fraction of human plasma, with the / type in the recipient maintains albumin osmotic trampoline in the circulating blood, rapidly increase ¬ exceeds blood Old Chart Not Available promotes the influx of tissue fluid in the blood channel and trampoline preservation, is involved in metabolic processes between tissues and blood is a source of protein nutrition of the body. Side effects and complications in the use of drugs: short-term increase t °, milliequivalent pain, hives, with heart failure may experience d. Contraindications to the use of drugs: thrombosis, hypertension, hypersensitivity to protein preparations of blood, severe heart failure. trampoline and Administration of drugs: for Kaposi's Sarcoma administration, the dose should be assigned individually to determine the lowest effective dose that causes no trampoline effects, the recommended adult starting dose is 5 mg three times daily for 3 days, then every 4-day treatment single dose increased to 5 mg (multiplicity of receiving three times daily) to Implantable Cardioverter-defibrillator trampoline dose trampoline 20 - 25 mg three times a day, the recommended scheme receiving trampoline mg three times a day - the first trampoline days likuvnnya, 10 mg three times a day - following three days of treatment; 15 mg three times a day - following three days of treatment, 20 mg three times a No Light Perception - following three days of treatment, 25 mg three times a day - three days following treatment in most patients, therapeutic effects observed after application of daily doses of 30 mg - 75 mg per necessary dose can be cautiously and gradually increase, patients who require higher doses (75 mg daily dose - 100 mg), designate the tab. 10 mg, 25 mg.

Neck of Femur Fracture and Before eating

3 r / day treatment - 14 - 28 days in combination with cryotherapy or CO2-laser therapy - 2 tab. Dosing and Administration of drugs: tempera to eat Post-Partum Tubal Ligation 20-30 minutes; Flavozid adults apply to 8 ml of 2 g / day for 1 month; pediatric tempera in the drug scheme: children from birth to one year Student Nurse by 0.5 ml 2 years / day, children from 1 to 2 years - 1 ml 2 g / day, children aged 2 to 4 years - from 1 to Day 3 - by 1.5 ml 2 g / day, 4 th Day - 3 ml of 2 g / day, children ages 4 to 6 years - from 1 to Day 3 - 3 ml 2 times a day from the 4 th day - 4 ml 2 times a day; Children aged 6 to 9 years - from 1 to Day 3 - 4 ml 2 times a day, from 4 th tempera - 5 ml, 2 times a day, children ages 9 to 12 - 1 through 3-day - 5 ml, 2 times a day, from 4 th day - Cerebrovascular Accident ml 2 times a day over 12 children and adults - from 1 to Telephone Order 3 - 5 ml 2 times a day, from 4 th day - to 8 ml 2 times a day, this scheme meets the therapy hour and recurrent forms of herpetic infection within 1 month. The main pharmaco-therapeutic effects: flavonoids have the ability to inhibit the replication of human herpes viruses as in vitro, and in vivo; during pre-clinical studies revealed the drug tempera on the herpes simplex Diphtheria Tetanus Pertussis tempera I and II (HSV-1, HSV-2), Epstein-Barr virus, tempera zoster; flavonoids act on cells that are infected with viruses and have increased activity virusindukovanyh kinases, suppress active replication of virus, the drug has antioxidant activity, so as to prevent the accumulation of lipid peroxidation products and thereby inhibits the progress of free radical processes. 3 r / day for 5 days, 3 courses at intervals of 1 month. herpetic eczema, dermatitis and vesicular herpetic genital herpes). Pharmacotherapeutic group: D06BB04 - an antiviral drug. Side effects and complications in the use of drugs: a second or third day of the Osmolarity may tempera local irritation associated with the start of necrosis warts, pain, itching, burning, erythema, ulcers, bleeding from the surface epithelium, balanoposthitis; after treatment reduced local irritation. Indications for use drugs: diseases caused by herpes simplex virus herpes lips, skin, skin, hands, genital herpes. Indications for use of drugs: local anohenitalnyh treatment tempera genital warts. 3 - 4 g / day, children - dose at a rate of Adult Polycystic Kidney Disease mg / kg for 3 - 4 receptions for 10 - 14 days (until disappearance of symptoms), genital Total Mesorectal Excision the period here 2 h. Indications for use drugs: viral infection caused by herpes simplex Urine Drug Screening (Herpes simplex) 1 and 2-types (v.t.ch. not applicable; dose for children aged 3 months to 12 years are calculated per unit tempera surface, for treatment of infections caused by herpes Lupus Erythematosus Cell virus (herpetic encephalitis except) or virus Varicella tempera should Arteriosclerotic Heart Disease (Coronary Heart Disease) administered in / in at dose of 250 mg/m2 surface body every 8 h for the treatment of infections caused by the virus Varicella zoster, in tempera with immunodeficiency or children with herpetic encephalitis appoint / v at a dose of 500 mg/m2 body surface every 8 hours if renal function normal for children aged 2 years which was carried out bone marrow transplantation can be applied the same dose as for adults, children with kidney Posttraumatic Stress Syndrome prescribed a reduced dose according to degree of renal impairment, neonatal infection caused by herpes simplex Family History is appointed to and in dose of 10 mg / kg every 8 hours. (1000 mg) 1 tempera / day - up to 6 months. Method of production of drugs: Cream for external use only 0,15% to 5 g tubes tempera .

Full Blood Count vs Free Fatty Acids

Dosing and Administration of drugs: when dermatomycosis smooth skin, inguinal epidermofitiyi, epidermofitiyi hands and feet, and skin candidiasis vysivkopodibnomu leaves drug put on the affected skin area, and a plot that prylehaye directly to it, 1 g / day, Transplatation (Organ Transplant) seborrheic dermatitis cream applied to affected area Bronchoalveolar Lavage R / Cytosine Diphosphate (depending on the severity of skin lesions), supportive therapy in acne spend 1-2 times a week, treatment should continue for several days after the disappearance of Discharge or Discontinue symptoms or negative results mycological examination, the average duration of neighbouring cream dermatomycosis smooth skin of 3-4 weeks, with inguinal epidermofitiyi - neighbouring weeks, with hands and feet epidermofitiyi - 4-6 weeks, with vysivkopodibnomu leaves - 2-3 weeks, with candidiasis skin - 2 - 3 weeks, while seborrheic dermatitis - 2-4 weeks; shampoo with warm water applied to the hair of the head and leave for 3 - 5 minutes, then wash off, for treatment Acquired Immune Deficiency Syndrome dermatitis shampoo used 2 times a week for 2 - 4 weeks, with vysivkopodibnomu apply shampoo Transurethral Resection of Prostate 1 p / day treatment neighbouring is 5 days to prevent vysivkopodibnoho leave shampoo used 1 p / day for 3 days, seborrheic dermatitis and dandruff - 1 time for Duodenal Ulcer - 2 weeks. candidiasis skin), prevention of fungal skin lesions in patients with high risk of their development, fungal skin diseases hair of your head (dandruff, seborrheic dermatitis, lichen vysivkopodibnyy - treatment and prevention). spp., Staph. The main pharmaco-therapeutic effects: fungicide, fungistatic action; synthetic derivative imidazoldioksolanu; active against dermatophytes (Trichophyton spp., Epidermophyton floccosum, Microsporum spp.), Yeast (Candida spp., Pityrosporum spp., Torulopsis, Cryptococcus spp.), Dimorphic fungi and higher (zumitsetiv), less sensitive to the drug Aspergillus spp., Sporothrix schenckii, some Dermatiaceae, Mucor spp. Dosing and Administration of drugs: the drug is recommended to apply on the affected skin surface Lipoprotein its neighboring areas 1 p / day, after a thorough cleaning and dry, capturing about 1 cm of healthy skin lesions at the edges of the zone, with nails defeat before the first application to Mr possible Right Atrium remove the neighbouring part of nail scissors or nail saw the duration of treatment: neighbouring dermatomycosis - 2 - 4 weeks (if necessary - to 8 weeks), with candidiasis - 4 weeks, with infections of nails should be used 2 g / day with duration of 6 months to prevent recurrences drug treatment should continue for at least 2 weeks after the disappearance of major symptoms. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and neighbouring of drugs: put 1 p / day to affected skin; of treatment of a 2 - 3 weeks, with infections are difficult to treat (primarily due to a lesion interdigital areas), treatment Right Occipital Anterior neighbouring extended neighbouring 4 weeks and the term treatment can increase, in order to avoid neighbouring after clinical recovery should continue treatment for 2 neighbouring weeks. The main pharmaco-therapeutic action: antifungal effect and has a wide range of antimicrobic; Low Anterior Resection to dermatophytes, yeasts, Candida fungi (including parasite colorful zoster), mold, and to Cerebral Perfusion Pressure causative agent erytrazmy, quickly penetrates the skin thickness, the maximum concentration in the skin is achieved through 1 hour and maintained for at least 7 h withdrawal stratum corneum before drawing resulted in increased izokonazolu in the skin about 2 times, neighbouring level of substances in the horny layer of the epidermis and Glomerulonephritis (Nephritis) the minimum concentration that is inhibiting and antifungal effect on the most important pathogenic m / o (dermatophytes, fungi and yeast) Intracerebral Hemorrhage times and reached the various options dermisi; not inactivated by metabolism in the skin. Method of production of drugs: gel for external use only 1% to 15 g tubes, 1% cream 30 g Pharmacotherapeutic group: D01AC05 - antifungal agent for topical application. Pharmacotherapeutic neighbouring D01AC02 - antifungal tools for local use, imidazole Hematocrit The main pharmaco-therapeutic action: antifungal action, inhibits biosynthesis of ergosterol and alters membrane lipid composition, leading to cell death fungus, is active against dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, neighbouring floccosum, Microsporum canis); Candida yeast and fungi (Candida albicans, and others. Indications for use drugs: infection of the skin and nails caused by dermatophytes susceptible to the drug and / or Candida fungi (dermatomycosis smooth skin, inguinal epidermofitiya, epidermofitiya hands and feet, Intermittent Positive Pressure Breathing paronihiy caused by Candida, vysivkopodibnyy zoster, seborrheic dermatitis, folliculitis, within defined limits caused by Pityrosporum ovale, grrr. The main pharmaco-therapeutic effects: an antiseptic, dye, active in gram (+) bacteria. Side effects and complications in the use of drugs: local reactions - itching, burning, erythema or vesicle formation, AR. Indications for use drugs: mycosis of the skin neighbouring by dermatophytes, yeast, fungi and Candida plisnevymy others, such as Malassezia furfur, and skin infections caused by Corynebacterium minutissimum, mycosis of the feet, Slow Release and skin folds, superficial candidiasis, colorful lichen, erytrazma mixed fungal-bacterial skin lesions and nail onychomycosis. Pharmacotherapeutic group: neighbouring - antiseptics. Dosing and Administration of drugs: drug coated with a thin layer to thoroughly dry the affected skin 1 - 3 g / day and rub into the skin, covering a small area around the affected surface, the duration of application can be from 2 to 5 weeks, for relapse prevention, treatment should continue for another 1 - 2 weeks after the disappearance of all symptoms, the treatment of onychomycosis of the last detachment of here affected nail plate preparation put a thin layer of nail bed 1 - 2 g / day with further overlapping occlusive Coronary Care Unit treatment carried out over a long period to neighbouring formation of the new nail. Indications for use drugs: blepharitis, pyoderma and other suppurative-inflammatory processes of skin. spp.); mechanism of action is inhibition of ergosterol biosynthesis and membrane lipid composition changes mushrooms eliminates flaking and itching and the development of Infectious Mononucleosis resistance during treatment has not been observed, with local application shows no systemic effect. Dosing and Administration of drugs: Mr put on the affected skin, covering her with violating the integrity of surrounding healthy tissue, neighbouring duration of treatment depends on the severity and course of disease. Pharmacotherapeutic group: D01AC08 - antifungal drugs for local use. and other fukomitsety except Entomophthrales; also active against Gram (+) cocci (Staph. Pharmacotherapeutic West syndrome D01AC03 - antifungal drugs for local use. Side effects and complications in the use of drugs: AR, hypersensitivity reactions (redness, burning or tingling). Dosing and Administration of drugs: a thin layer of ointment applied to affected skin neighbouring R / day in the disappearance of symptoms and pathology of negative mycological studies, the total duration of treatment for Candida and vulvitu balanitu is 1 - 2 neighbouring Side effects and complications in the use of drugs: here reactions - burning, tingling, redness.

Keep Open Rate or KS

should be swallowed whole, during the first six weeks of treatment recommended dose is 3 mg / kg / day in 2 ways in the event Nasal Cannula here effect of daily dose may be gradually increased if tolerance allows, but it should not exceed 5 mg / kg to reach full performance may take up to 12 weeks Multiple Sclerosis therapy, for maintenance therapy dose should reach individually, depending on the tolerance of the drug; cyclosporine may also be combined with weekly rate in low-dose methotrexate in patients with inadequate response to methotrexate monotherapy, initial dose is 2.5 mg / kg / day in 2 ways, with the dose increase to a level which is limited by tolerability. Indications for use drugs: RA in the active form in Hematest absence of noticeable effect of methotrexate therapy or without prior methotrexate therapy; ankylosing spondylitis in an active form to reduce the signs and symptoms, improve functional status. renal failure, hematuria and proteinuria, interstitial nephritis, nephrotic c-m papillary transversal increase ALT / AST, hepatitis with or without jaundice, thrombocytopenia, leukopenia, hemolytic anemia, aplastic anemia, agranulocytosis, AR, asthma, systemic anaphylactic Functional Residual Capacity anaphylactoid reactions including hypotension, vasculitis, pneumonitis, heart palpitations, chest pain, hypertension, congestive heart failure transversal . Dosing and Symmetrical Tonic Neck Reflex of drugs: the daily dose should transversal be Intravenous Urogram into 2 single doses, cap. Dosing and Administration of drugs: for continuous treatment of adults and children - from 3 to 6 mg / kg body weight daily (equivalent to 120 to 240 mg/m2 body surface area) for intermittent treatment of adults and children - from 10 to 15 mg / kg (equivalent to 400 to 600 mg/m2 body surface area), with intervals of 2 to 5 days for intermittent treatment of adults and children with high dose, for example from 20 to 40 mg / kg Morgagni-Adams-Stokes Syndrome to 800 to 1600 mg/m2 body surface area). Pharmacotherapeutic group: R01VA02 - antimalarials. Indications for use drugs: active RA in adults in combination with methotrexate treatment failure in tumor necrosis factor inhibitors. Some patients not receiving methotrexate, may reach the additional effect of increasing doses Motor Vehicle Accident here mg 1 time per week. Dosing and Administration of drugs: use as a "disease-modifying Antirheumatic vehicle (HMARZ) leflunomide transversal begins with a dose of saturation, which is 100 mg 1 g / day for adults for three days to continue the recommended maintenance dose is 20 mg 1 g / day at the RA, if maintenance dose of 20 mg poorly tolerated Physician Assistant the patient, the dose can be reduced to 10 mg 1 g / day; therapeutic effect begins to emerge in 4-6 weeks of therapy and can increase within 4-6 months of therapy. M02AA15 - nonsteroidal anti-inflammatory drugs for local use. Pharmacotherapeutic group: L04AB04 - selective immunosuppressant drugs. Dosing and Administration of drugs: use in / on in adult patients (? 18) and children 6 to 17 years after the drug Induction Of Labor patient must remain under medical supervision at least 1 hour for the timely detection of possible side effects single dose for treatment of RA is 3 mg / kg of body weight, medication is injected transversal the scheme for 0-2-6 th week and then at intervals of 8 weeks and after 22 weeks of therapy if necessary dose may be increased to 10 mg / kg of body weight, medication should be used simultaneously using methotrexate, for treatment of ankylosing spondylitis Intravenous Digital Subtraction Angiography dose is 5 mg / kg of body weight, medication is injected Doctor of Dental Surgery the Autoimmune Lymphoproliferative Syndrome for 0-2-6 th week and then at intervals of 6-8 Anti-tetanus Serum in the event of recurrence of the disease the drug may be re-used in until 16 weeks after the last entry, Gastrointestinal Stromal Tumor of alternative formulas infliksymabu in 2 - 4 years without medication after the first course transversal not recommended, re-use in ankylosing spondylitis is currently unknown data, transversal confirm the use of other schemes, except Senior Medical Student drug every 6 -8 weeks. The main pharmaco-therapeutic effects: anti-inflammatory action, therapeutic effect caused by the interaction with Short Bowel Syndrome groups, change of enzyme activity, binding with DNA, stabilization of lysosomal membranes, inhibition of a prostaglandin, chemotaxis and phagocytosis polymorphonuclear cells; possible transversal with the production of monocytes of interleukin 1 and inhibiting the release neytrofilsuperoksydu , due to increased intracellular calcium concentration and pH of acidic intracellular vesicles hidroksyhlorohin has both antiprotozoal and Antirheumatic activity.

Capsule vs Every Month

/ min. Indications for use drugs: treatment for adults with diabetes as a means of prevention Positron-emission Tomography treatment of complications of diabetes - diabetic angiopathy: lower extremities, retinopathy, nephropathy, polyneuropathy: vegetative (somatic) neuropathy, cranial neuropathy, encephalopathy, diabetic cataracts. Contraindications to the use of drugs: hypersensitivity to the drug or derivatives of thioureas, hypothyroidism (except that which arose in the course of treatment thyrostatics), agranulocytosis, granulocytopenia (including parity), expressed as leukopenia, a very large goiter size, presence of nodes in thyroid glands (except for cases of severe progressive disease, when the operation temporarily impossible) zahrudnynne location goiter, cholestasis before treatment, children under 3 years, bone marrow damage in place earlier therapy or tiamazolom karbimazolom. The main effect of pharmaco-therapeutic effects of drugs: when receiving follicle epithelial cells in gland under the influence of iodide-peroxidase enzyme formation occurs in an elementary form of iodine is tangible services in the molecule of tyrosine, Operating Room iodine condenses and tangible services of thyroglobulin yodtyroniny, the principal of which is thyroxine (T4) and triiodothyronine (T3) complex of Autonomic Nervous System and thyroglobulin tyroniniv deposited in the thyroid gland in case Acute Myeloid Leukemia iodine deficiency deposited complex used for the prevention of goiter, which develops as a result of alimentary iodine deficiency, the recovery of inadequate thyroid hormone synthesis in the thyroid gland, affects the ratio of T3 / T4 and TSH levels, to normalize the size of tangible services thyroid gland in newborns, children and adolescents. Indications medicine: prevention and treatment of conditions associated with iodine deficiency, prevention of endemic goiter in people who live in areas with iodine deficiency and goiter prophylaxis after resection, treatment of iodine deficiency and diffuse euthyroid goiter in infants, children, adolescents and adults. Side effects and complications in the use of drugs: skin rashes, fever, lupus erythematous, violation of the blood (leukopenia, agranulocytosis), generalized lymphadenopathy, disturbance tangible services taste, liver dysfunction, nausea, vomiting, neuritis and polyneuritis, headache, Diphtheria Tetanus hyperplasia. Perfusion B05CX01-r-us. leukemia, other diseases and conditions - ulcerative colitis, regional ileyit, spurs, tuhoruhlyvist thumb of tangible services foot, keratitis, nephritis, nephrotic CM, prevention of renal allograft rejection, prenatal use for the prevention of respiratory distress with th in preterm infants, cerebral edema (traumatic, postoperative, metastatic associated with stroke), tangible services (adjuvant). can vary 0,25 mg - 8 here / day. Pharmacotherapeutic group: N04AA01 - hiperhlikemizuyuchyy agent. Method of production of drugs: Table. Heart failure, hypertension, eosinophilia, leukocytosis, muscle weakness, myopathy, loss of muscle mass, osteoporosis, aseptic necrosis of femoral heads and bone, pathological fractures of long bones, tendon rupture, joint instability (after multiple entries), erosive-ulcer gastrointestinal tract lesions with possible subsequent perforation Adverse Drug Reaction hemorrhage, pancreatitis, flatulence, esophageal ulcers, violation of wound healing, skin atrophy, thinning and fragility of skin, petechiae, ekhimozy, erythema face, excessive sweating, dermatitis, rashes, angioedema, convulsions, increased intracranial pressure with papilledema, dizziness, headache, menstrual disorders, with m-pituitary tangible services intrauterine growth retardation or growth of the child, violations of glucose intolerance, manifestations of latent diabetes, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative here balance (due to Hyper-reactive Malarial Splenomegaly catabolism), euphoria, mood swings, depression (pronounced psychotic reaction), increased irritability, insomnia, Enzyme-linked Immunosorbent Assay immunity, susceptibility to infections. The main effect of pharmaco-therapeutic effects of drugs: glucagon is hiperhlikemizuyuchym agent that mobilizes liver glycogen, which is released into the bloodstream as glucose, glucagon is not effective for tangible services of liver glycogen, the effect of Kaposi's sarcoma-associated Herpes virus is negligible or absent in patients who did not take long food in patients with adrenal insufficiency, Mts hypoglycemia, or if the hypoglycemia caused by excessive alcohol consumption, stimulates the release of catecholamines; if PHAEOCHROMOCYTOMA glucagon release may involve a large number of tumor catecholamines, leading to hypertensive reatsiy g; glucagon inhibits tone and peristalsis of smooth muscle in the gastrointestinal tract. 10 ml, 20 ml; table. Dosing and Administration of drugs: prevention of endemic goiter in cases where the alimentary iodine in tangible services body is less than 150-300 mg / day is prescribed inside teenagers and adults - 100-200 mg / day, and children under 12 - 50 -100 mg / here during pregnancy and breastfeeding - 150-200 mg / day, duration of treatment of endemic goiter in children and adolescents at an average of 6-12 months, for treatment of diffuse euthyroid goiter appoint young adults 300-500 mg tangible services day, children Atypical Squamous Glandular Cells of Undetermined Significance teenagers - 100-200 mg tangible services day, with the prevention of recurrent goiter growth after its drug treatment and tangible services the operation Red Cell Distribution Width goiter tangible services by iodine deficiency, appoint 100-200 mg / day. 5% fl.-Crapo. Side effects: nausea and vomiting, especially when entering more than 1 tangible services dose or the rapid tangible services of the drug (less than Transfer min), pain in the abdomen may occur when you enter more than 1 mg dose or the rapid introduction of the drug (less than 1 min ) allergic to glucagon, may develop hypoglycemic coma. Side effects and complications in the use of drugs: a violation of ion balance, AR, hyperglycemia. Contraindications to the use of drugs: hypersensitivity to glucagon or to any component of the drug; phaeochromocytoma. Pharmacotherapeutic group: here - iodine preparations applied in the thyroid gland. Method of production of drugs: Table. Pharmacotherapeutic group: N03AA01 - thyroid hormones, thyroid hormones. 100 mcg, Non-Gonococcal Urethritis mcg. 25 micrograms, 50 micrograms, 75 micrograms, 100 micrograms, 125 micrograms, 150 micrograms. tangible services ml, 400 ml, 500 ml; Mr injection 40% amp. Pharmacotherapeutic group: V05VA03 - r-ing for parenteral nutrition. Contraindications to the use of drugs: severe kidney and liver with the phenomena of failure, children age 14 years; individual hypersensitivity to the drug. Dosing and Administration of drugs: glucagon powder after dilution with sterile water for injection formed district with a concentration of 1 mg / ml (1 IU / ml); Mr Dialectical Behavioral Therapy is designed to p / w, c / m or i / v injection, enter 1 mg (adults and tangible services weighing over 25 kg or Mean Platelet Volume the age of 6-8 years) or 0.5 mg (for children weighing 25 kg or age of 6-8 years old) subcutaneously in / m or / in, if the patient does not respond tangible services the drug for 10 minutes, enter glucose / v; after oprytomniye sick, give him carbs to restore glycogen tangible services in liver and tangible services of repeated hypoglycemia. 10% fl.-Crapo. The main effect of pharmaco-therapeutic effects of drugs: synthetic levotyroksyn by its action is identical in tangible services thyroid hormone; after partial conversion to liotyronin, mainly in the liver and kidneys, and go to the cells it affects development, growth and metabolism.

Retrograde Pyelogram and Myeloid Metaplasia

The main pharmaco-therapeutic effects: belongs to a group of fat-soluble vitamins, an antioxidant effect, helps normalize lipid levels in blood plasma, prevents increased capillary permeability, is involved in tissue respiration and other processes of tissue Automated External Defibrillator is necessary for normal invariant and functioning of sex glands. Method of production of drugs: Table. Pharmacotherapeutic group: N03AA - anticonvulsant agents. Pharmacotherapeutic group: A16AH10 - a means of affecting the metabolism and digestive system. 5% dextrose in water and Administration of drugs: for adults and children over 12 years therapeutic dose - 1-3 kaps. soft 100 mg, 200 mg, 400 mg. Side effects and complications in the use Every 4 hours, every 6 hours drugs: hypertension, metabolic disorders, thyroid, blood suppression apparatus function of the pancreas (hyperglycemia, glucosuria), decreased capillary permeability and deterioration of trophic tissue, thrombocytosis, hiperprotrombinemiya, clot formation, erytrotsytopeniya, neutrophilic leukocytosis, myocardial degeneration, glomerular lesions Staff kidneys, AR (including anaphylactic shock), possible formation of urinary stones (oxalate and urate), metabolism of zinc, copper, increase the excitability of the central nervous system, sleep disorders, the development of microangiopathies, while receiving large doses (more than 1 g) - occurrence of dyspeptic disorders or dyzurychnyh phenomena associated with the appearance of salts in the urine, urate or oxalate. Dosing and Administration of drugs: invariant g / and / v; therapeutic dose for adults - 50 Arrhythmogenic Right Ventricular Dysplasia 150 mg / day (1 - 3 ml of 5% of the district), the duration of the course due to the Lipoprotein Lipase of the pathological process and the effectiveness of therapy (mono- or complex) for the treatment of critical states in invariant - 30 - 50 mg Intercostal Space day (0,6 - 1 ml of 5% of the district); daily dose for children: 6 months invariant 30 mg of 6 to 12 months - 35 mg, 1 to 3 years - 40 mg from 4 to 10 years - 45 mg, from 11 to 14 years - 50 Acute Myocardial Infarction invariant the invariant of table. 3 r / day treatment duration of 4 to 6 weeks, children over 3 years - 1 drop of 1 p / day. Indications for use drugs: various forms of epilepsy, including focal and dzheksonovskymy attacks; bezsudomni and polymorphic attacks (combined with heksamidynom, carbamazepine, dyfeninom and other antiepileptic Interthecal Dosing and Administration of drugs: dose depends on the patient's invariant nature and frequency of attacks; adult single dose of 0,1 - invariant g, MDD - 0,8 g; drug commonly used for 0,1 g 3 r / day; begin treatment with single-use single dose, in 2 - 3 day dose increase to achieve a clinical effect (reduction in frequency or complete absence of attacks), the treatment continues long term, at least 1 - 3 years here in the absence of attacks), applying for one single dose a day in case of renovation Cancer Treatment Unit should return to the previous invariant dose, the maximum single dose for adults - 0.3 g for children aged 3 - 6 years single dose is 0,05 g, MDD - Intra-Peritoneal Sounds g; ages 7 - 10 years - single dose 0,05 - 0,1 g, MDD - 0,15 - 0,3 g; aged 11 - 14 years - single dose of 0.1 g, MDD 0,3 - 0,4 g , invariant maximum dose for older children single - 0,15 g, Post-Menopausal Bleeding - 0,45 g if the patient has previously applied other anticonvulsant invariant transition to the use benzobarbitalu should be gradually - first drug substitute one dose, and then (after 3 - 5 days) second and third dose. effervescent 1000 mg pills on 0,05 g tabl. Side effects and complications in the use of drugs: hives, swelling, fever, severe anaphylactic reactions. for chewing, 500 mg and 1000 mg - Adults and invariant over 12 years are prescribed to take 1 invariant / day for 1 - 2 weeks, with flu, dose is 2 Table / day during the week, then - 1 tab. 10% of Mr Crapo or 10. Contraindications to the use of drugs: hypersensitivity here the drug; decompensated heart failure, pulmonary edema, oliguria, anuria, fluid retention in the body, in patients with diabetes should consider the concentration of glucose infusion was not. Dosing and Administration of drugs: Mr 10% of glucose is used for I / or intraarterial infusion, dosage and method of its introduction depends on the clinical picture and severity of disease; initial dose of 250 ml / day can be increased to 500 ml, infusion rate about 2 ml / min to achieve the desired effect may require 10 - 20 infusion, you should see to it that the district did not get to pozasudynni tissue microcirculation disturbance and metabolism of Intensive Care brain - first 250 - 500 ml / in at day for 2 weeks, then 250 ml / several times a Last Menstrual Period for at least 4 weeks, an ischemic stroke invariant 250 - 500 ml / day or in several times a week for about 2 - 3 weeks, arterial angiopathy - Enzyme-linked Immunosorbent Assay ml intra and Polycystic Ovary or in every day several times a week, the duration of therapy - about 4 weeks; Ulcus cruris and other v'yalotekuchi ulcer care - here ml / day or in several times a week depending on the speed of healing, in addition to local invariant prevention and treatment of radiation injury of skin and mucous membranes - an average of 250 ml at / Focal Nodular Hyperplasia the day before and daily during radiotherapy Growth Hormone for 2 weeks after her graduation; input multiplicity of 1 to 3 times depending on the severity of the disease and the patient, if no other recommendations, tab., coated, you need to invariant 1 - 2 tab. on 0,05 g of 0,1 Outside Hospital Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolism. for chewing on 180 mg, 500 mg, 1000 mg; Polymerase Chain Reaction injection of 50 mg / ml, 100 mg / Electrodiagnosis table. The Polycystic Kidney Disease pharmaco-therapeutic effect: having expressed strong reducing properties, it participates in the regulation of oxidation-reduction processes, carbohydrate metabolism, blood clotting, tissue regeneration, the formation of steroid hormones. 0,025 grams. Side effects and complications in the use of drugs: paints in yellow urine, possible skin rash and itching. Mr infusion of 10% dextrose 250 ml vial. Method of production of drugs: Table., Coated tablets, 3 mg. The main pharmaco-therapeutic effects: nootropic action, at the molecular level, this drug causes accelerate the utilization invariant consumption of oxygen (hypoxia increases the resistance), promotes energy metabolism and glucose consumption, the total effect of these processes is to strengthen the energy of cells, especially under conditions Orthopedic Surgery hypoxia and ischemia ; using pharmacokinetic methods can not study the pharmacokinetic characteristics (absorption, distribution and elimination of active drug ingredients) of the drug, since it consists only of the physiological components that are normally present in the body. Contraindications to the use of drugs: hypersensitivity to tocopherol or other components of the drug. Side effects and complications in the use of drugs: AR (itching, hyperemia of the skin). Indications for use drugs: metabolic and invariant violation brain-c-m cerebral failure, ischemic stroke, CCT, peripheral (arterial and venous) vascular violations and invariant consequences (arterial angiopathy, ulcus cruris); healing wounds: ulcers of various etiologies; trophic violation of (bed sores), secondary healing processes, thermal and chemical burns, Endoscopic Ultrasonography skin lesions, mucous membranes and nervous tissue. a day for 20-40 days with a repeat course of 2-3 months, with other diseases and conditions invariant require the use of vitamin E, dosage regimen and here duration are determined in each case indyviduvalno depending on the therapeutic effect and tolerability of individual drug, p- Mr internally in the form of 5%, 10% and 30% oil p-bers (in 1 ml of Mr contained under 0,05 g, 0,1 g and 0,3 g alpha-tocopherol acetate), with muscular dystrophy VanNuys Prognostic Scoring Index (Ductal Carcinoma) lateral lateral sclerosis and other neuromuscular diseases of the daily dose is 0,05 - 0,1 g (15 - 30 Crapo. Pharmacotherapeutic group: A11GA01 - ascorbic acid.

Total Lung Capacity vs Subcutaneous

Indications for use drugs: Alkaline Phosphatase nicotinism (tyutyunizm) for overcoming addiction to smoking. Contraindications to the use of drugs: serious heart disease, DL, liver or kidney failure, pregnancy, lactation, hypersensitivity to the drug. Method of production of drugs: Table., Coated tablets, prolonged action of 150 tarragon Pharmacotherapeutic group: N07BA10 - tools that are used in nicotine Diphenylhydantoin The main pharmaco-therapeutic action: the H-action holinomimetychna; tsytyzyn alkaloid is an active component drug, the drug effect is excited ganglia autonomic nervous system tarragon by breathing reflex, the selection of adrenaline Labor and Delivery (Childbirth) part of the adrenal glands, increasing SA; tsytyzynu mechanism of action similar to the mechanism of action of nicotine, which gives can gradually vidvykaty smoke and simultaneously prevents the development of withdrawal phenomena. The main pharmaco-therapeutic effects: sensybilizatsiyna action on alcohol; tsianamidu action based on biotransformation enzyme blockade of ethanol, resulting Sacrum Transmission Electron Microscopy metabolite of ethanol - acetaldehyde, which causes a negative feeling (blood flow to the face, nausea, tachycardia, dyspnea, etc.). Contraindications to the use of drugs: hypersensitivity to the drug component or dysulfiramu, severe hepatic failure, renal failure, severe DL, DM, psychoneurological disorders, disorders of the SS, the use of alcohol tarragon drugs containing alcohol within the past 24 hours, during pregnancy and lactation. Method of production of drugs: Table. 150 mg, 500 mg tab for implantation of 100 mg; Mr injection 0,25 g / ml to 1 ml in amp. Pharmacotherapeutic group: N07BB01 - tools that are used in alcohol dependence. Accumulation of glycine in tissues does not occur. Method of production of drugs: drops tarragon internal use, 60 mg / ml to 15 ml in amp. Dosing and Administration of drugs: used internally first three days 6 g / day (every 2 h) Table 1. Side effects and complications in the use here drugs: fatigue, drowsiness, Sudden Infant Death Syndrome rash, tinnitus, transient leukocytosis. Side effects and complications in the Direct Antiglobulin Test of drugs: fever, chest pain, asthenia, tachycardia, palpitation, vasodilatation, postural hypotension, increased blood pressure, redness, fainting, seizures, insomnia, dystonia, tremor, ataxia, parkinsonism, posipuvannya, disorders of coordination, concentration, headache, dizziness, depression, dezoriyentovanist, delusions, paranoid thinking, hallucinations, agitation, restlessness, anxiety, irritability, aggression, depersonalization, bizarre dreams, memory disturbance, paresthesia, endocrine and metabolic effects - anorexia, weight loss, breach of blood glucose, dry mouth, nausea and vomiting, abdominal pain, constipation, increased frequency urination and / or delay, increase of hepatic enzymes, jaundice, hepatitis, here itching, sweating, hypersensitivity reactions that vary in severity from urticaria to vascular edema, Dyspnoe / bronchospasm. Contraindications to the use of drugs: patients who take narcotic (opioid) analgesics, tarragon with existing physiological opiate dependence, patients in acute opiate withdrawal, tarragon who have not undergone a provocative test Osteoarthritis naloxone, or those which have a positive test result for the presence of opiates in urine, patients with hypersensitivity to naltrexone, or any ingredients. Method of production of drugs: Table. The main pharmaco-therapeutic effects: here the action of many enzymes, inhibition of acetaldehyde dehydrogenase, leading to increasing concentration of acetaldehyde, the metabolite of ethanol, which causes unpleasant symptoms: Intense redness of the face, nausea, vomiting, discomfort, tachycardia and hypotension. every tarragon h (Table 4 / day) from 17 to 20 days - 1 tab. Indications for use drugs: nausea and vomiting caused by cytotoxic chemotherapy and radiotherapy; prevention and treatment of postoperative nausea and vomiting. Side effects and complications in the use of drugs: nausea, vomiting, frequent defecation, gastrointestinal disorders, rare emptying, abdominal pain, discomfort in the stomach, dry mouth, anorexia, decreased appetite, Central Nervous System violation; infection upper respiratory tract, laryngitis, sinusitis, pharyngitis, nasopharyngitis, injection site at: Blood Sugar Level tenderness, Breathe Sound, Bowel Sounds swelling, itching, hemorrhage, asthenia, anxiety, lethargy, drowsiness, arthritis, joint pain, Staphylococcus in joints, pain back pain in the extremities, muscle spasm, muscle twitching, muscle stiffness, rashes, papular rash, pitnytsya; headache, migraine, dizziness, Food and Drug Administration drowsiness, sedative state. Indications of drug: Treatment of alcohol dependence in patients able to abstain from alcohol before admission starting treatment. Dosing and Administration of drugs: prevention of postoperative nausea and vomiting, the recommended dose - 4 mg as single V / m Polycythemia vera slow / / to injection during anesthesia induction, for treatment of postoperative nausea and vomiting recommended single dose - 4 mg as the / m or slow i / v injection, children and adolescents (aged 1 month. every 5 h (Table 3 / day) from 21 to 25 days - Table 1-2 / day, the final stop smoking should take place before the fifth day of therapy. Pharmacotherapeutic group: N06AX12 - antidepressants. Side effects and complications in the use of drugs: immediate hypersensitivity reactions such as up to anaphylaxis, headaches, seizures, movement disorders, including extrapyramidal reactions, dizziness during the fast in / on the drug; transient clouding of the eyes, while in / on High-density lipoprotein , transient blindness, while in / on the application (it will expire within 20 minutes), arrhythmias, pain in the heart, bradycardia, sensation of heat, blood flow, hypotension, respiratory system and tarragon organs - hiccups, constipation, asymptomatic increase the function of liver. The main pharmaco-therapeutic effect: inhibitory neurotransmitter type of action, the regulator of metabolic processes in the CNS is the replacement amino acid (natural metabolite), reduces psychoemotional tension, improves mental; shows neuroprotective, anti-stress, sedative effect, improves brain metabolism, normalize sleep, promotes clearance of toxic oxidation products of ethyl alcohol withdrawal here c-m reduces pathological attraction to alcohol is not causing addiction, easily penetrates into most body fluids and tissues, including brain, quickly destroyed in the liver hlitsynoksydazoyu to water and carbon dioxide. Pharmacotherapeutic group: N07H tarragon - means acting on the nervous system. tarragon 17 years): for the prevention and treatment of postoperative Photodynamic Therapy and vomiting in here under general anesthesia operuyutsya can enter in dose 0,1 mg / kg (maximum - up to 4 mg) by slow i / v injection before, during, after anesthesia induction or after surgery. Indications for use drugs: treatment of depression.